Press Releases

Oncodesign Services and Nexus BioQuest Form Preclinical Partnership

Yuvraj — Sat, 19 Sep 2026 08:36:39 +0000

Oncodesign Services and Nexus BioQuest have formed a partnership designed to connect complementary in vitro and in vivo capabilities, giving biotech companies a clearer route to specialist preclinical expertise as their development programs advance. Announced in Dijon, France – 16 September, 2026, the collaboration brings together Nexus BioQuest’s human-relevant in vitro capabilities and Oncodesign Services’ […]

The post Oncodesign Services and Nexus BioQuest Form Preclinical Partnership first appeared on World Pharma Today.

ACHEMA 2027 Strengthens India Process Industry Collaboration

Yuvraj — Fri, 18 Sep 2026 23:00:42 +0000

DECHEMA, EEPC INDIA and Messe Frankfurt India brought together more than 200 industry leaders, business stakeholders and professionals from India’s process, chemical, pharmaceutical and engineering sectors at a Networking Evening in New Delhi on 8 September 2026. Held at Hotel Shangri-La Eros, New Delhi, the event focused on industry interactions, knowledge exchange and business networking, […]

The post ACHEMA 2027 Strengthens India Process Industry Collaboration first appeared on World Pharma Today.

Onyx Scientific Boosts API Manufacturing Capacity in UK

Yuvraj — Fri, 18 Sep 2026 22:51:07 +0000

Onyx Scientific, a global small molecule CDMO, is investing more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities and increase commercial active pharmaceutical ingredient (API) production at its Sunderland UK facility. The expansion will add four GMP suites, taking the total from six to ten, while increasing capacity for commercial API production and […]

The post Onyx Scientific Boosts API Manufacturing Capacity in UK first appeared on World Pharma Today.

Neuland Expands Peptide Manufacturing Capacity in India

Yuvraj — Fri, 18 Sep 2026 22:31:56 +0000

Neuland Laboratories is accelerating its peptide manufacturing expansion, with the first of four planned modules now operational at its commercial peptide manufacturing site in Hyderabad. The company said the newly commissioned module is designed to meet growing customer demand and support programmes ranging from small-scale to multikilogram quantities for complete peptide APIs, including complex and […]

The post Neuland Expands Peptide Manufacturing Capacity in India first appeared on World Pharma Today.

Choosing the Right Supply Chain Strategy for Pharma Growth – Live Webinar

Yuvraj — Tue, 15 Sep 2026 07:27:44 +0000

Pharmaceutical and life sciences businesses face stringent requirements around batch control, traceability and compliance, which cannot be an afterthought when scaling warehouse operations and supporting pharma growth. Ryan Gibbs and Grant Smith will examine these supply chain considerations in an upcoming webinar, “New Build, 3PL, AGV, AMR or AutoStore Robotics? Choosing the Right Supply Chain […]

The post Choosing the Right Supply Chain Strategy for Pharma Growth – Live Webinar first appeared on World Pharma Today.

groninger at PACK EXPO International 2026 in Chicago

Yuvraj — Fri, 11 Sep 2026 14:13:40 +0000

At one of North America’s most important industry trade shows, groninger will demonstrate how decades of fill-finish expertise, extensive capabilities in secondary processing, and a strong lifecycle services portfolio come together to create an end-to-end solution approach. “Our core expertise clearly lies in the filling and closing of pharmaceutical liquids. At the same time, we […]

The post groninger at PACK EXPO International 2026 in Chicago first appeared on World Pharma Today.

Complex-molecule specialist Shilpa CDMO launches at CPHI Milan

Yuvraj — Thu, 10 Sep 2026 14:15:51 +0000

Shilpa CDMO*, a dedicated complex small-molecule contract development and manufacturing organisation will launch next month at CPHI Milan. The new brand, separate from parent company Shilpa Medicare, provides a specialist development and commercial manufacturing partner for biotech and pharma customers with complex small molecules, building on Shilpa’s more than 30 years of oncology expertise. Keshav […]

The post Complex-molecule specialist Shilpa CDMO launches at CPHI Milan first appeared on World Pharma Today.

Syntegon delivers continued sales growth and margin expansion in first-half 2026 based on strong Pharma business momentum

Yuvraj — Tue, 08 Sep 2026 07:25:23 +0000

• Strong first-half momentum with sales up 7% year-on-year to EUR 883 million; Pharma business drives Group growth, with sales up by 14%, outpacing market growth • Adjusted EBITDA rises 16% to EUR 148 million; EBITDA margin expands by 130 basis points to 16.8%, supported by improved project margins • Order intake of EUR 964 […]

The post Syntegon delivers continued sales growth and margin expansion in first-half 2026 based on strong Pharma business momentum first appeared on World Pharma Today.

Syntegon opens new OSD Customer Center in Fellbach

Yuvraj — Wed, 02 Sep 2026 13:34:12 +0000

State-of-the-art customer center for the pharmaceutical and nutraceutical industries Customer focus, innovation, and growth under one roof Close collaboration between customer center and production for even faster time-to-market of new drugs and nutraceuticals Stuttgart (Germany), September 1, 2026. Syntegon, a strategic lifecycle partner to the pharmaceutical, biotech, and food industries, has opened its new OSD […]

The post Syntegon opens new OSD Customer Center in Fellbach first appeared on World Pharma Today.

Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases

Yuvraj — Fri, 28 Aug 2026 08:15:42 +0000

New global brand creates a stronger platform for innovation, partnerships and growth At the SSIEM Annual Symposium in Helsinki, Galen Ltd and POA Pharma announced the launch of Galsana, a new global brand for their metabolic product portfolio, bringing together established products, expertise and support services under a single identity. Galsana represents the next stage […]

The post Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases first appeared on World Pharma Today.